Concepedia

Myeloma Pathogenesis

Myeloma Pathogenesis is a biomedical construct that delineates the molecular and cellular mechanisms underlying the initiation, progression, and clinical manifestations of multiple myeloma within hematopoietic tissues.

5.1K

Publications

334.2K

Citations

21.8K

Authors

3.5K

Institutions

Publications per year

2017–2026

1K

Parents

Publications

5.1K

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo et al. · The Lancet Oncology · 2014 · 4.9K citations · Full text

, , +11

Improved survival in multiple myeloma and the impact of novel therapies

Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri et al. · Blood · 2007 · 2.3K citations · Full text

, , +14

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

Michio Kawano, Toshio Hirano, Tadashi Matsuda et al. · Nature · 1988 · 1.7K citations

, , +11

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro et al. · Immunity · 1999 · 1.7K citations · Full text

, , +16

The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins

Gang Lu, Richard E. Middleton, Huahang Sun et al. · Science · 2013 · 1.6K citations · Full text

, , +14

1–5 of 5.1K

Authors

21.8K

  1. KC
    Kenneth C. Anderson

    Dana-Farber Cancer Institute, United States

    184 publications · 32.7K citations

    87

    h-index

  2. BB
    Bart Barlogie

    University of Arkansas for Medical Sciences, United States

    114 publications · 19.8K citations

    72

    h-index

  3. NC
    Nikhil C. Munshi

    Dana-Farber Cancer Institute, United States

    122 publications · 18.5K citations

    70

    h-index

  4. TH
    Teru Hideshima

    Dana-Farber Cancer Institute, United States

    91 publications · 14.2K citations

    63

    h-index

  5. PG
    Paul G. Richardson

    Dana-Farber Cancer Institute, United States

    75 publications · 20.7K citations

    59

    h-index

1–5 of 21.8K

Institutions

3.5K

  1. Dana-Farber Cancer Institute

    Boston, United States

    106 h-index

    2.3K publications

    351.9K citations

  2. Mayo Clinic in Arizona

    Scottsdale, United States

    87 h-index

    1K publications

    213.1K citations

  3. University of Arkansas for Medical Sciences

    Little Rock, United States

    86 h-index

    1.1K publications

    190.8K citations

  4. Inserm

    Paris, France

    78 h-index

    930 publications

    101K citations

  5. Harvard University

    Cambridge, United States

    77 h-index

    1.4K publications

    197.1K citations

  6. Mayo Clinic

    Rochester, United States

    69 h-index

    634 publications

    80K citations

  7. National Cancer Institute

    Bethesda, United States

    61 h-index

    468 publications

    72.6K citations

  8. Heidelberg University

    Heidelberg, Germany

    53 h-index

    581 publications

    52.9K citations

1–8 of 3.5K

Venues

  1. Blood

    804 publications · 106.7K citations

    181

    h-index

  2. Leukemia

    234 publications · 22.1K citations

    85

    h-index

  3. British Journal of Haematology

    BJH · 222 publications · 14.1K citations

    65

    h-index

  4. PubMed

    Repository · 403 publications · 17K citations

    64

    h-index

  5. Oncotarget

    106 publications · 5K citations

    44

    h-index

1–5